Literature DB >> 11182467

Hippocampal volume discriminates between normal cognition; questionable and mild dementia in the elderly.

H Wolf1, M Grunwald, F Kruggel, S G Riedel-Heller, S Angerhöfer, A Hojjatoleslami, A Hensel, T Arendt, H Gertz.   

Abstract

The sensitivity of MRI volumetric measures to detect cognitive dysfunction is examined in 39 participants of an epidemiological field study (age 75-85, MMSE 19-30). According to Clinical dementia rating (CDR), 17 subjects had normal cognition (CDR 0), 12 had questionable (CDR 0.5) and 10 mild dementia (CDR 1). Discriminant analysis based on four hippocampal measures resulted in a correct classification of 76.9% of all subjects. Left-sided and posterior hippocampal measures were more responsible for group discrimination than right-sided and anterior measures. In CDR 0.5, a significant hippocampal volume reduction of 14.3% vs.11.3% (left vs. right) relative to normal was found. The right hippocampus was significantly greater than the left in CDR 0 and CDR 0.5, but not in CDR 1. The magnitude of non-directional hippocampal asymmetry increased with decreasing cognitive state. We conclude that hippocampal atrophy is sensitive to detect cognitive dysfunction and subjects at risk for Alzheimer's disease in the elderly population.

Entities:  

Mesh:

Year:  2001        PMID: 11182467     DOI: 10.1016/s0197-4580(00)00238-4

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  46 in total

1.  In vivo analysis of hippocampal subfield atrophy in mild cognitive impairment via semi-automatic segmentation of T2-weighted MRI.

Authors:  John Pluta; Paul Yushkevich; Sandhitsu Das; David Wolk
Journal:  J Alzheimers Dis       Date:  2012       Impact factor: 4.472

2.  Anatomical and functional correlates of human hippocampal volume asymmetry.

Authors:  Austin A Woolard; Stephan Heckers
Journal:  Psychiatry Res       Date:  2012-01-27       Impact factor: 3.222

3.  Hippocampal atrophy confounds template-based functional MR imaging measures of hippocampal activation in patients with mild cognitive impairment.

Authors:  C K Sandstrom; S Krishnan; M J Slavin; T-T T Tran; P M Doraiswamy; J R Petrella
Journal:  AJNR Am J Neuroradiol       Date:  2006-09       Impact factor: 3.825

4.  Hippocampal atrophy on MRI in frontotemporal lobar degeneration and Alzheimer's disease.

Authors:  L A van de Pol; A Hensel; W M van der Flier; P-J Visser; Y A L Pijnenburg; F Barkhof; H Josef Gertz; P Scheltens
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-11-23       Impact factor: 10.154

5.  Familial risk for Alzheimer's disease alters fMRI activation patterns.

Authors:  Susan Spear Bassett; David M Yousem; Catherine Cristinzio; Ivana Kusevic; Michael A Yassa; Brian S Caffo; Scott L Zeger
Journal:  Brain       Date:  2006-05       Impact factor: 13.501

Review 6.  Neuropsychological differences between frontotemporal dementia and Alzheimer's disease: a review.

Authors:  Michal Harciarek; Krzysztof Jodzio
Journal:  Neuropsychol Rev       Date:  2005-09       Impact factor: 7.444

Review 7.  Neuropsychological contributions to the early identification of Alzheimer's disease.

Authors:  Mark W Bondi; Amy J Jak; Lisa Delano-Wood; Mark W Jacobson; Dean C Delis; David P Salmon
Journal:  Neuropsychol Rev       Date:  2008-03-18       Impact factor: 7.444

8.  Automated ventricular mapping with multi-atlas fluid image alignment reveals genetic effects in Alzheimer's disease.

Authors:  Yi-Yu Chou; Natasha Leporé; Greig I de Zubicaray; Owen T Carmichael; James T Becker; Arthur W Toga; Paul M Thompson
Journal:  Neuroimage       Date:  2007-12-08       Impact factor: 6.556

9.  Knowing the natural course of biomarkers in AD: longitudinal MRI, CSF and PET data.

Authors:  W M Van Der Flier; P Scheltens
Journal:  J Nutr Health Aging       Date:  2009-04       Impact factor: 4.075

10.  Neuropsychological prediction of conversion to dementia from questionable dementia: statistically significant but not yet clinically useful.

Authors:  J Tian; R S Bucks; J Haworth; G Wilcock
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-04       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.